Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MMX Mesalamine
DRUG
2 trials
Sponsors
Shire
Conditions
Ulcerative Colitis
Phase 1
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Completed
NCT01130844
Shire
Ulcerative Colitis
Start: 2010-10-08
End: 2013-06-27
Updated: 2021-06-14
Phase 4
Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)
Completed
NCT00446849
Shire
Ulcerative Colitis
Start: 2007-05-01
End: 2009-08-17
Updated: 2021-06-14
Related Papers
Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis
Drug Design Development and Therapy
2016-02-01
11 citations
PTU-091 Multimatrix mesalazine in paediatric ulcerative colitis: a pharmacokinetic and safety study
Gut
2015-06-01
P540. Efficacy and safety of infliximab's biosimilar (REMSIMA) for IBD
Journal of Crohn s and Colitis
2015-02-01
2 citations
P539. Outcome of acute severe ulcerative colitis in patients previously exposed to immunosoppressive therapy
Journal of Crohn s and Colitis
2015-02-01
Long-term Pooled Safety Analysis of Once-Daily Multimatrix Mesalamine
The American Journal of Gastroenterology
2014-10-01
1 citations